Document Detail


Defective suppressor cell activity in cancer patients: a defect in immune regulation.
MedLine Citation:
PMID:  6452944     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Although suppressor cells appear to be involved in the normal regulatory mechanism of the lymphoid system, they are also considered to have a role in the immunosuppression of certain malignancies. Suppressor activity of lymphocytes can be reproducibly measured by use of the mixed lymphocyte culture-mitogen interaction (MLC-M) in which the stimulating cell either is in the basal state or has been induced by Concanavalin A. This yields a quantitative measure of resting suppressor cell activity as well as the maximum generation of suppressor activity as induced by Con A. This test was performed, using autologous and allogenic cell combinations in a group of 13 cancer patients and 18 normal controls. Normal lymphocytes activated by Con A in 48-hour lymphocyte cultures significantly decreased the mitogenic response of lymphocytes from healthy, male donors to phytohemagglutinin (PHA), Con A, and Pokeweed mitogen (PWM) in both autologous and homologous systems. In contrast, Con A activated lymphocytes from cancer patients demonstrated diminished suppressor activity compared with controls in autologous (P less than 0.01), and allogenic (P less than 0.005) systems. There was a correlation between the degree of immunosuppression and suppressor cell activation: i.e., the patients most depressed generally had the lowest suppressor cell activation. Untreated lymphocytes from cancer patients also exerted suppressive effects on normal lymphocyte responses, suggesting an increased resting level of suppressor cells. These data suggest that in addition to having depressed cellular immune responses, cancer patients frequently have reduced capability to generate suppressor cell activity, which implies a generalized defect in this aspect of immune regulation.
Authors:
G W Hubbard; H Wanebo; M Fukuda; R Pace
Related Documents :
6221934 - Characterization of a subpopulation in neonatal thymus which suppress the graft-vs.-hos...
3157314 - A lymphoproliferative disorder of t gamma cells with the phenotype of cytotoxic/suppres...
9406284 - Regulation of mouse immuno-responses by a natural suppressor cell clone from bone marrow.
21330314 - Expression of follicular helper t cell markers in nodal peripheral t cell lymphomas: a ...
15295384 - Neurogenic cells in human amniotic fluid.
8156314 - Aplastic anaemia associated with fenbufen: a report of two cases.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Cancer     Volume:  47     ISSN:  0008-543X     ISO Abbreviation:  Cancer     Publication Date:  1981 May 
Date Detail:
Created Date:  1981-07-20     Completed Date:  1981-07-20     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0374236     Medline TA:  Cancer     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  2177-84     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Cells, Cultured
Gastrointestinal Neoplasms / immunology*
Head and Neck Neoplasms / immunology*
Humans
Immunity, Cellular
Immunosuppression
Male
Mitogens / pharmacology
T-Lymphocytes, Regulatory / drug effects,  immunology*
Grant Support
ID/Acronym/Agency:
2 R25 CA 17990-03/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Mitogens

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The effect of prolonged physical training and high fat diet on heart size and body weight in rats.
Next Document:  Phase II study of chlorozotocin in the treatment of advanced colorectal cancer.